chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt's son reported pt became short of breath and confused while in the waiting area after receiving vaccine. Upon assessment, pt was hypotensive at 90/60 with O2 sat of 91% on room air. EMS called and provided pt with oxygen via nasal cannula.  Pt transported to hospital for further evaluation.
Patient called and said that he felt awful ever since getting the vaccine. He complained of red blotches/patches on the skin of hands and feet that were itchy. Upon application of 1% hydrocortisone OTC ointment on 07/04/2019 evening, the itching subsided, but he mentioned on 07/05/2019 that the rashes still remained. When I asked him if there was any muscle pain in the right arm where the vaccine was given, he declined of any such pain or itching specific to that area. He also complained of pain due to heel spurs and just not feeling well. He also mentioned that he felt cold at the night of 07/04/2019 and felt like he needed a blanket. He mentioned that he will wait it out for 2 days and if he didn't get better, he will visit a local doctor. He thinks that all of this must be related to getting the Tdap vaccine on 07/03/2019
"Pt began complaining of dizziness approximately 15 minutes following her COVID-19 vaccination while she was waiting in the waiting room for the recommended 30 minutes post-immunization due to having anaphylaxis to other allergens. Pt was brought back to an exam room and 50 mg IM Benadryl was administered by RN.  Following this, patient claimed to begin feeling better within 5 minutes and denied any further symptoms. Patient refused EMS or additional  care because she had a scheduled Dr appointment with at 1:40PM that day."
cloudy vision in right eye which lasted for 2 hours after waking. Seen by my regular ophthalmologist at 1:00 pm that day. Based on ophthalmologist's concern for detached retina or TIA, she contacted my PCP who instructed me to go to the ER for a stroke evaluation. Had blood work and a head CT-scan . Saw a retina specialist several days later, but no eye damage detected. Also, my Apple Watch recorded irregular rhythm on December 28, 2021 but no A-fib detected by cardiologist.
Painful and erythematous injection site extending to axilla with fever beginning around 12-16 hours after vaccine.  In clinic , two days later with fever and injection site reaction
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old male patient received BNT162b2 (BNT162B2), on 01Apr2021 as dose 1, single (Lot number: ER8737), in right arm, on 22Apr2021 as dose 2, single (Lot number: ER8735), in right arm, on 18Dec2021 as dose 3 (booster), single (Lot number: FD7218), in left arm and on 13May2022 as dose 4 (booster), single (Lot number: FM9992) at the age of 62 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "No" (unspecified if ongoing), notes: Other medical history: No. The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (11Jul2022) Negative, notes: Tested neg on (Test Kit Name withheld) molecular 11Jul2022; (17Jul2022) Positive, notes: Tested positive on (Test Kit Name withheld) molecular 17Jul, 18Jul and still positive on 19Jul; (18Jul2022) Positive, notes: Tested positive on (Test Kit Name withheld) molecular 17Jul, 18Jul and still positive on 19Jul; (19Jul2022) Positive, notes: Tested positive on (Test Kit Name withheld) molecular 17Jul, 18Jul and still positive on 19Jul. Therapeutic measures were taken as a result of drug ineffective, covid-19.Clinical Course:Anti-viral details Product COVID 19 Treatment, Brand Paxlovid, Treatment start date Jul2022. Treatment stop date: Jul2022. Indication: Treatment of COVID-19. Adverse events start date was 17Jul2022. AE resulted in none of the above.  Patient was not recovered, no treatment AE.  No follow-up attempts are possible. No further information is expected.
Covid-19; covid-19; This is a spontaneous report from a contactable Physician via Pfizer sales representative. This Physician reported for a 48-year-old-male patient received a dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EY0572 and expiry date was not reported), via an unspecified route of administration, on 29Jul2021 (age at vaccination: 47 years), as unknown, a single dose for COVID-19 immunization at workplace clinic. The patient's medical history and concomitant medications were not reported. The patient did not have any known allergies. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. On 17Sep2021, the patient experienced Covid-19. Prior to vaccination, the patient was not diagnosed with Covid-19. Since the vaccination, the patient was tested for Covid-19. There was no hospitalization prolonged. The patient did not receive any treatment. The patient underwent lab test and procedure Covid test with Negative result (Other, Covid test name post vaccination: Saliva) on 05Sep2021. Outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of serious events Drug ineffective and COVID-19 cannot be totally excluded.
SORE ARM; ITCHING; GENERALIZED RASH; This spontaneous report received from a patient concerned a 56 year old female. The patient's weight was 153 pounds, and height was 64 inches. The patient's concurrent conditions included hay fever, non smoker, and non alcoholic, and other pre-existing medical conditions included the patient had drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 17-APR-2021, the subject experienced itching. On 17-APR-2021, the subject experienced generalized rash. On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from generalized rash, and the outcome of itching and sore arm was not reported. This report was non-serious.
1 days p/vax pt devel focal hemorrhages in subdural area;the reporter, ped neurologist eval pt & stated that looks like pt is a subject of child abuse & dx shaken baby synd;A defense attorney allegedly attributes this event to Acel-immune;
I am experiencing what I am going to call brain or head zaps or electric shocks when I get up to do anything. I have no symptoms while I am sitting still. But anytime I get up I get a series of these electric head shocks. Last night I also had upper stomach abdominal pain but that has cleared up and so has most of the soreness in my left arm. I want to know if it's really advisable for me to take the 2nd shot in 3 months time considering this reaction.
FEVER; This spontaneous report received from a patient concerned a 26 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.. No concomitant medications were reported. On 12-MAR-2021, the subject experienced fever. On 12-MAR-2021 11:45, Laboratory data included: Body temperature (NR: not provided) 103.7 degrees F. On 12-MAR-2021 22:00, Laboratory data included: Body temperature (NR: not provided) 104 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever. This report was non-serious.
received a shingles vaccine and subsequently had a Shingles outbreak/Suspect vaccination failure; received a shingles vaccine and subsequently had a Shingles outbreak; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The reporter was in the general public, not a patient.  The reporter inquired about Shingrix and vaccine hesitancy in general.  The reporter stated that people she knows have received a shingles vaccine and subsequently had a Shingles outbreak.  When asked for more details about the patients the reporter cited just a guy at my church. The reporter did not know the year the conversation with the patient occurred or which vaccine he received and she did want to provide additional details and ended the call. The reporter did not consent to follow-up. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting.
Muscle pain and spasms  Day #4 - 7, L shoulder and L neck. Required Vicodin for pain control. Severe fatigue, sleepiness, intermittent nausea, body aches days 7-21. Mental "fuzziness" and sense of imbalance, fatigue persisted days 22-29.  Symptoms gradually improved and resolved by day #30.  Unable to do normal activity days #4 - 21, diminished activity days 21-30.
Severe vertigo for 1/2 day with nausea.  Vertigo continued for 4 more days in the morning,  accompanied with weakness.   After 2 weeks, dizziness and weakness disappeared.  I only think it is from the vaccine, for my husband, who got the vaccine the same day I did, had an onset of extreme vertigo while he was driving.  His symptons came the one day after my vertigo attack.
Patient states he had no symptoms the evening after the injection given at 3:30pm. He states when he woke about around 7am he was unable to lift or move his arm.  He was at our office by 7:30 am to be evaluated.
Patient experienced headache, shortness of breath, left side arm and leg numbness and mild diarrhea after one hour receiving the Covid 19 vaccine. This is the second dose.
patient received flu vaccine on Monday afternoon, on Monday night started feeling pain to her left am, reported experiencing pain, swelling and warmth in her left arm since Monday night,  Weds night pain worse.  today (Thursday redness has decreased).  Area painful to touch on exam, denies no fever or chills.  dx cellulitis, given Keflex 500mg QID x 5 days and to use warm compresses then alternate with cool and warm compresses, advised to take Tylenol or motrin as needed for pain relief
Pt came in for well child exam August 19,2019 with father. No complaints at this time. Father reports son just moved from another country was starting school. Vaccines were given. Father reports August 20,2019 at 6pm son reports he complained of his left arm itching. Father reports left upper arm was red and warm to touch. Father denies any fever, nausea, change in behavior, or rash anywhere else. This morning father took a picture of area and sent child to school. After school, father reports son said area was still itching. Father brought son into clinic. Son was seen by Nurse practitioner. Exam as follows- mild erythema and warmth noted to left deltoid. No fever, tachycardia, or shortness of breath noted. Area was circled with a pen, Informed father to monitor redness and if it spread, to bring child pt to clinic. Father understood. Educated on cool compress and anti-itch cream prn.
Information has been received from a physician concerning a 76 year old female with stress (recently) who on 09-JUN-2008 was subcutaneously vaccinated with a 0.64 ml dose of ZOSTAVAX (Oka/Merck). Concomitant therapy included alendronate sodium (MSD). On 12-JUN-2008 the patient developed several red blotches on her right chest area and neuralgia pain behind her right ear and face. Approximately 6 days after vaccination, on 14-JUN-2008 the event broke out in shingles and the patient had a large amount of vesicles on her chest (a rather extensive distribution of shingles). Medical attention was sought, the patient was seen by a physician. The patient was given VALTREX. The patient's neuralgia recovered and her shingles persisted. On 16-JUN-2008 the VZV sample was obtained and on 26-JUN-2008 VZV identification program resulted indicated that it was a wild type strain. Follow up information was received which reported the patient had a history of chickenpox but no recent exposure to chickenpox or shingles and there were many lesions distributed in patient's left anterior wall and left upper extremity "posterior cervical", the patient was afebrile. The sample was collected from left axillary field. Additional information is not expected.
Nausea, fever, intense shivering, fainting, hyperventilating, increased blood pressure, overwhelming tired.
Trauma Progress Note  Note initiated:  10/8/2023 by MD   Hospital Day(s): 16   Injuries:  (Fall on 9/22/23; Transferred from Medical Center on 9/22/23.) ? SAH ? Pontine stroke - ischemic ? Facial fractures ? Pelvic fracture ? Hematuria ? Urethral injury ? Left vertebral artery injury   Other Diagnoses: ? Post trauma respiratory failure ? HTN ? Hypothyroid ? BPH ? Covid Positive   Operations & Procedures: Pt in house Bed
Itching in different parts of the body/Itching started/other arm/now it is on the waist; Arm Hurt; Did not feel well; Headache; General Aches/Pain; Itching in arm below the elbow; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching in different parts of the body/Itching started/other arm/now it is on the waist), PAIN IN EXTREMITY (Arm Hurt), MALAISE (Did not feel well), HEADACHE (Headache) and MYALGIA (General Aches/Pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced PRURITUS (Itching in different parts of the body/Itching started/other arm/now it is on the waist), PAIN IN EXTREMITY (Arm Hurt), MALAISE (Did not feel well), HEADACHE (Headache), MYALGIA (General Aches/Pain) and VACCINATION SITE PRURITUS (Itching in arm below the elbow). At the time of the report, PRURITUS (Itching in different parts of the body/Itching started/other arm/now it is on the waist) had not resolved and PAIN IN EXTREMITY (Arm Hurt), MALAISE (Did not feel well), HEADACHE (Headache), MYALGIA (General Aches/Pain) and VACCINATION SITE PRURITUS (Itching in arm below the elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
Pt. states that after receiving the 2nd dose of Moderna 02/04/2021, started experiencing symptoms of soreness of the Left arm and fatigue. Symptoms lasting 3 days, throat and sinus congestion with Mucus (yellow or green at time) have developed shortly after 2nd dose. Confusion at times "brain fog" and loss of appetite. No noted Primary visit/communications.
feverish; joint pain; injection site pain; headache; injection site pain radiating to the elbow.; This case was reported by a consumer via call center representative and described the occurrence of fever in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 4th December 2019, the patient received the 2nd dose of Shingrix. On 4th December 2019, less than a day after receiving Shingrix, the patient experienced fever, joint pain, injection site pain, headache and radiating pain. On an unknown date, the outcome of the fever, joint pain, injection site pain, headache and radiating pain were unknown.   It was unknown if the reporter considered the fever, joint pain, injection site pain, headache and radiating pain to be related to Shingrix.  Additional details were provided as follows:  The patient stated that she received the first dose of the Shingrix vaccine on 11th September 2019 and did not have any reactions. The patient received the second dose of the Shingrix vaccine in her right arm and stated at night she had whole body joint pain, headache, felt feverish and had injection site pain in her right arm radiating to the elbow.  No additional information provided. The reporter consented to follow up.
SORE ARM; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm. This report was non-serious.
achy; feverish; arm was killing her; This case was reported by a pharmacist via call center representative and described the occurrence of pain in a 78-year-old female patient who received Herpes zoster (Shingrix) (batch number 47JA3, expiry date 12th May 2020) for prophylaxis.   On 17th June 2019, the patient received the 2nd dose of Shingrix. In June 2019, less than a day after receiving Shingrix, the patient experienced pain, fever and pain in arm. On an unknown date, the outcome of the pain, fever and pain in arm were recovered/resolved.   It was unknown if the reporter considered the pain, fever and pain in arm to be related to Shingrix.  Additional details were provided as follows: Pharmacist reported that a patient was achy, feverish and her arm was killing her after her dose of Shingrix. The patient experienced symptoms within a day after vaccination with Shingrix. The pain, fever and pain in arm was lasted for 3 days after vaccination. The patient reportedly spoke with other women who received Shingrix, dose closer to the two month mark rather than six months experienced a higher rate of symptoms. The reporter did not have information for the other patients mentioned. The reporter consented to follow up. This case has been linked with case US2019AMR113878, reported by same reporter.
Pain in the left arm never went away after receiving flu shot.  The pain has increased throughout the upper arm.  Now there is constant general pain.  Sensitive to pressure.  Pain wakes me from sleep at night.  Some limited mobility with the arm
Feel terrible after having our 3rd dose/Felt like death all night after 3rd dose; Aches; High temperature; Terrible headache; first 2 doses were a different one; This spontaneous case was reported by another health care professional and describes the occurrence of FEELING ABNORMAL (Feel terrible after having our 3rd dose/Felt like death all night after 3rd dose), PAIN (Aches), PYREXIA (High temperature), HEADACHE (Terrible headache) and INTERCHANGE OF VACCINE PRODUCTS (first 2 doses were a different one) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Nov-2021, the patient experienced FEELING ABNORMAL (Feel terrible after having our 3rd dose/Felt like death all night after 3rd dose), PAIN (Aches), PYREXIA (High temperature), HEADACHE (Terrible headache) and INTERCHANGE OF VACCINE PRODUCTS (first 2 doses were a different one). On 20-Nov-2021, INTERCHANGE OF VACCINE PRODUCTS (first 2 doses were a different one) had resolved. At the time of the report, FEELING ABNORMAL (Feel terrible after having our 3rd dose/Felt like death all night after 3rd dose), PAIN (Aches), PYREXIA (High temperature) and HEADACHE (Terrible headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. Treatment medications were not provided.   This case was linked to MOD-2021-395583 (Patient Link).
Seven days after received Dose 1 of Pfizer Covid-19 vaccine, right arm was swollen and uncomfortable, the next day was purple.  He want to urgent care center who thought he had "Covid arm" and was put on prednisone.  Arm worsened, so he went to ER in middle of night on 5/4/21.  He was given shot of Lovenox and sent home to return in am for ultrasound. Ultrasound next morning showed right subclavian vein DVT.  He was put on Eliquis and told to follow up with hematologist.  He is working on getting appointment with a hematologist before flying home, where he will do further work up with hematologist there.
Work at hospital. Mandatory flu shots. Received my shot morning of 9/10/15 w/in 48 hrs hands were swollen, could not shut my hands, red, hot. Within 5 day shoulder.
I noticed significant swelling and increased pain at the injection site when I went to bed. (The deltoid area had swollen a bit by the first night after injection, so this was the second night. ) I took  an OTC sleep aid (50 mg diphenhydramine) and drifted off by 1 am. At 3 am I awoke, whether due to my usual   polynocturia or the vaccination reaction I can't say. My upper body, especially my arms and hands, was violently shaking and I had a blinding headache--and likely a fever, too. After that, I awoke at 4, 5, 7 and 8 am, during which time the shaking and headache subsided. I was very tired and my whole body was sore, so I went back to bed and slept until 10 am. By midafternoon, I was back to normal.
It has been over 14 days since my injection, yesterday my left arm became sore, red and hot to the touch